Efficacy of lead-in silibinin and subsequent triple therapy in diff...
... Efficacy of lead-in silibinin and subsequent triple therapy in difficult-to-treat HIV/hepatitis C ... with silibinin before triple therapy in difficult-to-treat patients. Methods: Inclusion criteria were ... Efficacy of lead-in silibinin and subsequent triple therapy in difficult-to-treat HIV/hepatitis C ... Efficacy of lead-in silibinin and subsequent triple therapy in difficult-to-treat HIV/hepatitis C ... Efficacy of lead-in silibinin and subsequent triple therapy in difficult-to-treat HIV/hepatitis C ...
Hepatocellular organic anion-transporting polypeptides (OATPs) and ...
... inhibited by silibinin. Drug Metabolism and Disposition, 41(8):1522-1528. Copy Abstract Silibinin has been ... . Although administered silibinin is well tolerated, increased serum bilirubin levels have been observed ... protein 2 (MRP2) are inhibited by silibinin - Zurich Open Repository and Archive Header Quicknavigation ... polypeptides (OATPs) and multidrug resistance-associated protein 2 (MRP2) are inhibited by silibinin Wlcek ...
An updated systematic review with meta-analysis for the clinical ev...
... systematic review electronic databases identified 65 papers for the search terms silymarin, silibinin ... identified 65 papers for the search terms silymarin, silibinin, silicristin or milk thistle and clinical ... databases identified 65 papers for the search terms silymarin, silibinin, silicristin or milk thistle and ... , silibinin, silicristin or milk thistle and clinical trial. Only 19 complied with the criteria'double-' or ...
Curriculum Vitae
... ; Multiple funders including UZH) 2013-2014 THISTLE: A Silibinin trial in HCV-HIV coinfection (Sponsor ... ; Multiple funders including UZH) 2013-2014 THISTLE: A Silibinin trial in HCV-HIV coinfection (Sponsor ...
Microsoft Word - KJMetzner_Publications_Oktober_2019.docx
... J. Fehr Efficacy of lead‐in silibinin and subsequent triple therapy in difficult‐to‐treat HIV ... silibinin prior to triple‐therapy translates into favorable treatment outcomes in difficult‐to‐treat HIV ... J. Fehr Efficacy of lead‐in silibinin and subsequent triple therapy in difficult‐to‐treat HIV ... silibinin prior to triple‐therapy translates into favorable treatment outcomes in difficult‐to‐treat HIV ...
Microsoft Word - 180208_Bibliography_Jan Fehr.docx
... , and the Swiss HIV Cohort Study. A lead-in with silibinin prior to triple-therapy translates into ... , Fehr J. Efficacy of lead-in silibinin and subsequent triple therapy in difficult-to-treat HIV/hepatitis ... , and the Swiss HIV Cohort Study. A lead-in with silibinin prior to triple-therapy translates into ... , Fehr J. Efficacy of lead-in silibinin and subsequent triple therapy in difficult-to-treat HIV/hepatitis ...
Integrative Human Physiology" - Zurich Open ">Items where Subject is "08 Research Priority Programs > Integrative...
... multidrug resistance-associated protein 2 (MRP2) are inhibited by silibinin. Drug Metabolism and Disposition ...
Browse by Communities & Collections - Zurich Open Repository and Archive
... polypeptides (OATPs) and multidrug resistance-associated protein 2 (MRP2) are inhibited by silibinin. Drug ...
Browse by Communities & Collections - Zurich Open Repository and Archive
... multidrug resistance-associated protein 2 (MRP2) are inhibited by silibinin. Drug Metabolism and Disposition ...
Browse by Communities & Collections - Zurich Open Repository and Archive
... (MRP2) are inhibited by silibinin. Drug Metabolism and Disposition, 41(8):1522-1528. Brouwer, K L R ...
